Best Life Sciences Companies in Charlotte, United States

Developer of a wearable-based data collection solutions for the prediction, early identification, and prevention of dementias and other health conditions. The wearable data collection technology enables researchers and clinicians to gather real-world data to improve healthcare outcomes. It monitor compliance and send notifications to ensure adherence, analyse data, and share results.

Funding rounds

• Aug 2025Grant (prize money)$2.5M
• Sep 2024Grant (prize money)$505.5K
• Sep 2021Grant (prize money)$1.9M

Founders & team

Jon CorkeyFounder & CEO

Investors

HHS

Tech stack

CloudflareContact Form 7ContentfulGoogle PagespeedHeadless UiHsts

Developer of drug delivery platform for brain diseases. It offers Brain Bispecific T cell Engager hitchhiking drug delivery platform with a ombination of novel T cell engager and specifically manipulated polyclonal T cells for oncology, central nervous system, autoimmune, and cardiovascular diseases.

Funding rounds

• Dec 2025Post IPO$1.7M
• Apr 2025Post IPO$7.7M
• Mar 2024Seed$1M

Founders & team

Michael RobertsCo-Founder & CEO

Biotech research: developing soybean seed-based therapeutics for disease treatment. The company focuses on biotechnology research to develop and validate soybean seed-based therapeutics. Their work aims to treat, prevent, cure, and diagnose diseases through innovative applications of soybean technology. They explore commercial applications and technology related to host systems. The company is dedicated to advancing healthcare solutions through plant-based research, contributing to the field of biotechnology with a focus on therapeutic development. This research has a social impact by potentially providing new and accessible treatments for various diseases.

Blood test for early breast cancer detection in dense breast tissue. The company develops innovative diagnostic and therapeutic products focused on cancer, particularly addressing unmet needs in detection and treatment. They utilize cutting-edge, patented technology to target tumor-associated MUC1 (tMUC1), a key cancer antigen. Their lead product, Agkura® Personal Score, is a simple blood test aiding breast cancer detection in women with dense breast tissue, where mammography alone is often insufficient. The company is also developing agents for tumor imaging and targeted drug delivery, aiming to improve cancer outcomes. Their business model centers on research and commercialization through strategic partnerships. This is a B2C and B2B healthcare and diagnostic company.

Funding rounds

• May 2025Grant (prize money)$400K
• Sep 2021Grant (prize money)$260.6K
• Sep 2021Grant (prize money)$400K

Founders & team

Rahul PuriCo-Founder & CEO

Investors

HHS

Medical technology company providing solutions for healthcare providers, caregivers, and patients. The company focuses on developing and manufacturing a wide range of medical devices and equipment. These include diagnostic cardiology, patient monitoring systems, healthcare furniture, and surgical solutions. The company offers products and services across various healthcare settings, such as hospitals, surgical centers, and home healthcare. The company aims to improve patient outcomes and enhance the efficiency of healthcare delivery through innovative medical technologies. The company provides solutions for vital signs monitoring, safe patient handling, respiratory therapy, and surgical workflow. The company also offers services like remote management, repair, and customer experience centers. The company's products incorporate advanced technologies and connectivity features.

Minimally-invasive prostate treatment using HIFU technology for precision prostate care. They are focused on transforming sound energy into focused healing, revolutionizing healthcare delivery for patients worldwide. They specialize in focal therapy for prostate disease, offering an alternative to conventional treatments. Their core values include innovation, communication, and customer success. They provide a customizable focal therapy option with robotic accuracy and real-time ultrasound feedback, ensuring patient safety. They are a global leader in HIFU technology, offering a minimally-invasive solution for prostate diseases. They are committed to making a positive impact on patient lives through their innovative technology.

Funding rounds

• Aug 2017Conventional Debt$3M
• Jul 2010Series B$1M
• Jul 2009Series B$5M
• 2008Series B$23M

Founders & team

MARK CAROLCEO & President

Investors

Decathlon Capital Partners, Galen Partners, MMV Financial, Hercules Capital

University of Pennsylvania: Education, research, community, and global impact. It provides access to services and information online while respecting user privacy. The institution collects and uses personal and other information for various purposes, including providing services, fulfilling requests, sending promotional materials, and improving user experience. Data analysis, security measures, and compliance with legal obligations are prioritized. Users have choices regarding their data, and the institution retains information as needed. Third-party services and advertising are utilized. The institution addresses cross-border data transfers and provides contact information for inquiries. It offers online learning, research, innovation, athletics, arts, culture, and community involvement. The website includes login, privacy policy, and resources for students, faculty, staff, parents, alumni, visitors, and media.

Provider of products for sleep and restless leg relief

Founders & team

Patrick RedmondFounder & CEO

Innovating orthopedic fixation with faceted bone screw technology for enhanced healing. This company is revolutionizing orthopedic fixation with its patented faceted threadform technology. Their bone screws offer lower insertional torque, increased bone contact, and higher pullout strength, promoting better osteogenesis and device apposition. They focus on advancing orthopedic solutions, providing surgeons with innovative tools for improved patient outcomes. Their products include small bone screw sets, headless compression screw sets, and cannulated screw sets. They are seeking distributors to expand the reach of their innovative product portfolio. They are committed to setting a new fixation standard in orthopedics.

Funding rounds

• Nov 2017Seed$3.5M
• Apr 2017Seed$625K

Founders & team

Roy BivensCEO

Investors

MagnaSci Ventures, Ellis Capital, Gaston Capital

Provider of genetically engineered spider silk from silkworms for commercial-scale production. The company has developed a process for large scale, inexpensive spider silk production from genetically engineered silkworms. EntoGenetics’ technology removes the silk gene from a silkworm and replaces it with spider silk gene. The inserted spider silk gene is then used by the silkworm to make its cocoon.

Funding rounds

• Jul 2013Seed$540.2K

Founders & team

David BrighamFounder & CEOTeresa BrighamCo-Founder

Vital Motion has developed a device for relieving the patient from fibromyalgia pain and symptoms. The Hummingbird is an FDA-registered device used to alleviate aches, pains, fatigue and other symptoms of fibromyalgia. The device applies micro-mechanical stimulation to the nerve-endings in the plantar surface of the foot to activate the soleus muscles in the calves for improving the blood flow throughout the body.

Funding rounds

• Apr 2015Seed$100K

Founders & team

Erik HiesterCo-FounderDavid LovenheimCEO

Investors

The Braunfeld Group

Developer of dental products and equipment. The company's product categories are dental consumable products, dental laboratory products, dental specialty products, and consumable medical device products. The company also manufactures urological catheters and surgical products.